Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 11;9(11):003637.
doi: 10.12890/2022_003637. eCollection 2022.

Hypomagnesaemia - One Cause To Remember!

Affiliations

Hypomagnesaemia - One Cause To Remember!

Ana Filipa Viegas et al. Eur J Case Rep Intern Med. .

Abstract

A 71-year-old female presented with 5 days of diarrhoea and asthenia. Past medical history of rheumatoid arthritis, arterial hypertension, hypertrophic cardiomyopathy and chronic gastritis was treated with leflunomide, deflazacort, esomeprazole, carvedilol and spironolactone. At admission, the patient's physical examination showed signs of dehydration. Lab results revealed leucocytosis, increased C-reactive protein, hypomagnesaemia, hypocalcaemia and hypokalaemia. A presumption of acute infectious diarrhoea causing hypomagnesaemia with hypocalcaemia and hypokalaemia was made. She was started on ciprofloxacin, IV hydration and electrolyte supplementation with an adequate response. However, magnesium levels fell repeatedly. After excluding other causes for hypomagnesaemia, chronic use of proton pump inhibitors (PPIs) was considered a plausible cause therefore PPI was discontinued, with normalisation of magnesium levels. Hypomagnesaemia is a common disturbance, mainly caused by diarrhoea, gastrointestinal malabsorption, medications, alcoholism and volume expansion. Clinical manifestations include neuromuscular symptoms, cardiovascular manifestations, hypokalaemia and changes in calcium metabolism. PPI-related hypomagnesaemia has been described in later years particularly in chronic use cases, with a medium prevalence of 27%, but further studies remain necessary to clarify its pathophysiologic mechanism. Since PPIs are widely used, it is essential to be aware of hypomagnesaemia as a possible side effect, particularly in refractory cases and after excluding other common causes.

Learning points: PPIs-related hypomagnesaemia should be a concern, especially in cases with refractory hypomagnesaemia and after excluding other common causes.Formal indication for PPIs use should be revised in most patients.

Keywords: Hypomagnesaemia; proton pump inhibitors.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interests: The authors declare there are no competing interests.

Figures

Figure 1
Figure 1
Evolution of magnesium levels over time

References

    1. Ahmed F, Mohammed A. Magnesium: The forgotten electrolyte—a review on hypomagnesemia. Med Sci (Basel) 2019;7:56. - PMC - PubMed
    1. Recart DA, Ferraris A, Petriglieri CI, Serena MA, Bonella MB, Posadas-Martinez ML. Prevalence and risk factors of long-term proton pump inhibitors–associated hypomagnesemia: a cross-sectional study in hospitalized patients. Intern Emerg Med. 2020;16:711–717. - PubMed
    1. Suksridechacin N, Kulwong P, Chamniansawat S, Thongon N. Effect of prolonged omeprazole administration on segmental intestinal Mg2+ absorption in male Sprague-Dawley rats. World J Gastroenterol. 2020;26:1142–55. - PMC - PubMed
    1. Srinutta T, Chewcharat A, Takkavatakarn K, Praditpornsilpa K, Eiam-Ong S, Jaber BL, et al. Proton pump inhibitors and hypomagnesemia. Medicine (Baltimore) 2019;98:1–9. - PMC - PubMed
    1. Plaut T, Graeme K, Stigleman S, Hulkower S, Woodall T. How often does long-term PPI therapy cause clinically significant hypomagnesemia? J Fam Pract. 2018;67:576–7. - PubMed

LinkOut - more resources